The Opioid Epidemic (B): Responses to the Crisis

  • Reference: SGSB-ETH18B-E

  • Year: 2020

  • Number of pages: 5

  • Geographic Setting: USA

  • Publication Date: Sep 20, 2017

  • Source: Stanford Graduate School of Business (USA)

  • Type of Document: Case

  • Industry Setting: pharmaceutical

Grouped product items
Format Language Reference Use Qty Price
pdf English SGSB-ETH18B-E
As low as €5.74

You already have a subscription

To order please contact the person in charge of academic purchases in your university.
You'll be able to order once your profile has been validated.

Description

Between 1999 and 2017, almost 400,000 Americans died from an opioid overdose. An average of 130 died each day in 2017, six times the daily rate in 1999. These deaths were caused by both prescription opioids and illegal opioids like heroin and illicitly manufactured fentanyl, or IMF. The most common drugs involved in prescription opioid overdose deaths were methadone, oxycodone (like OxyContin), and hydrocodone (like Vicodin). The A case, which is intended for use in a business ethics class, describes the background to and explores the causes of the current opioid epidemic. This B case follows on the A case and outlines responses to the crisis as of 2020.

Keywords

distributors epidemic kickbacks Lobbying Marketing opioid pain pharmaceutical